Loading company…
Riskpilot
← Back to search
Sign in
Get full access
DR.ING KNUT WIIK AS
AS
Active
Org 918619488
Ørvikveien 9, 3970 Langesund
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2017
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 744K
+31% vs 2024
EBITDA margin
79.4%
+6% vs 2024
Equity ratio
96.4%
Financial strength
Net profit 2025
NOK 1,4M
-61% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2021
0M
0%
2022
0M
0%
2023
1M
+100%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 744K
+31%
EBITDA
NOK 591K
+6%
Net profit
NOK 1,4M
-61%
Total assets
NOK 13,6M
+0%
Equity
NOK 13,1M
-1%
Employees
0
—
Company information
Legal name
DR.ING KNUT WIIK AS
Org number
918619488
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24. februar 2017
Share capital
NOK 80 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Å utvikle og selge teknologi, samt å investere i og utvikle bedrifter.
Contact
Address
Ørvikveien 9, 3970 Langesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Bamble
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
1M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
342
376
342
569
744
Staff expenses
−0
−0
−0
−0
−0
EBITDA
331
366
330
555
591
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
331
366
330
555
591
Net financials
3 021
40
3 528
3 270
1 063
Profit before tax
3 352
406
3 858
3 826
1 653
Tax
77
88
138
224
234
Net profit
3 274
318
3 720
3 602
1 419
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
5 791
6 126
9 887
13 620
13 623
Equity
5 617
5 935
9 655
13 207
13 127
Long-term debt
0
0
0
0
0
Short-term debt
174
191
233
413
497
Total debt
174
191
233
413
497
Financial ratios
5-year trend
EBITDA margin
79.4%
This company
15.8%
Market median
+403% vs market
2021
2025
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
2021
2025
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
2021
2025
Net profit margin
190.9%
This company
8.1%
Market median
+2257% vs market
2021
2025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2021
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KW
Knut Wiik
Chairman
2017
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
DR.ING KNUT WIIK AS
(this company)
PURENVIRO AS
Board network connections
Board members of DR.ING KNUT WIIK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Knut Wiik
Chairman
0 companies